Prior studies examining the association of FGF23 with markers of inflammation and insulin resistance were limited by a focus on chronic kidney disease (CKD) populations [12], small sample size and/or lack of race and sex diversity [13,14]. This evidence concerns the gene FGF23 and chronic kidney disease.